← Browse by Condition
Medical Condition

papillary renal cell carcinoma type 2

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05096390 Phase 2
Recruiting

Axitinib +/- Pembrolizumab in First Line Treatment of mPRCC

Enrollment
72 pts
Location
France
Sponsor
Centre Leon Berard
View Trial →